Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1381 AL 1395

Single-Cell RNA Sequencing in Parkinson's Disease

Ma SX, Lim SB.

Biomedicines. 2021 Apr 1;9(4):368. doi: 10.3390/biomedicines9040368.

Molecular Mechanisms of Astaxanthin as a Potential Neurotherapeutic Agent

Bahbah EI, Ghozy S, Attia MS, Negida A, Emran TB, Mitra S, Albadrani GM, Abdel-Daim MM, Uddin MS, Simal-Gandara J.

Mar Drugs. 2021 Apr 3;19(4):201. doi: 10.3390/md19040201.

Multi-Layer Picture of Neurodegenerative Diseases: Lessons from the Use of Big Data through Artificial Intelligence

Termine A, Fabrizio C, Strafella C, Caputo V, Petrosini L, Caltagirone C, Giardina E, Cascella R.

J Pers Med. 2021 Apr 7;11(4):280. doi: 10.3390/jpm11040280.

Biomaterials for Drugs Nose-Brain Transport: A New Therapeutic Approach for Neurological Diseases

Cassano R, Servidio C, Trombino S.

Materials (Basel). 2021 Apr 6;14(7):1802. doi: 10.3390/ma14071802.

Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives

Magistrelli L, Ferrari M, Furgiuele A, Milner AV, Contaldi E, Comi C, Cosentino M, Marino F.

Int J Mol Sci. 2021 Apr 6;22(7):3781. doi: 10.3390/ijms22073781.

Developing a Consistent, Reproducible Botulinum Toxin Type A Dosing Method for Upper Limb Tremor by Kinematic Analysis

Samotus O, Lee J, Jog M.

Toxins (Basel). 2021 Apr 8;13(4):264. doi: 10.3390/toxins13040264.

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs

Silva S, Almeida AJ, Vale N.

Pharmaceutics. 2021 Apr 8;13(4):508. doi: 10.3390/pharmaceutics13040508.

A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson's Disease Affects LRRK2 Protein Levels

Ogata J, Hirao K, Nishioka K, Hayashida A, Li Y, Yoshino H, Shimizu S, Hattori N, Imai Y.

Int J Mol Sci. 2021 Apr 2;22(7):3708. doi: 10.3390/ijms22073708.

Dual Roles of Microglia in the Basal Ganglia in Parkinson's Disease

Choudhury ME, Kigami Y, Tanaka J.

Int J Mol Sci. 2021 Apr 9;22(8):3907. doi: 10.3390/ijms22083907.

A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far

Lasaponara S, Marson F, Doricchi F, Cavallo M.

Brain Sci. 2021 Apr 21;11(5):528. doi: 10.3390/brainsci11050528.

Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia

Albert K, Niskanen J, Kälvälä S, Lehtonen Š.

Int J Mol Sci. 2021 Apr 21;22(9):4334. doi: 10.3390/ijms22094334.

PINK1: A Bridge between Mitochondria and Parkinson's Disease

Gonçalves FB, Morais VA.

Life (Basel). 2021 Apr 21;11(5):371. doi: 10.3390/life11050371.

Molecular Mechanisms Underlying the Beneficial Effects of Exercise on Brain Function and Neurological Disorders

Nay K, Smiles WJ, Kaiser J, McAloon LM, Loh K, Galic S, Oakhill JS, Gundlach AL, Scott JW.

Int J Mol Sci. 2021 Apr 14;22(8):4052. doi: 10.3390/ijms22084052.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias